| Trial ID: | L0463 |
| Source ID: | NCT00169923
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease
|
| Acronym: |
Hercules
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Inflammation
|
| Interventions: |
DRUG: rosiglitazone
|
| Outcome Measures: |
Primary: intima media thickness, 48 weeks | Secondary: carotid artery calcifications, 48 weeks|inflammation, 48 weeks|lipid profile, 48 weeks|metabolic profile, 48 weeks|pulse wave velocity, 48 weeks|nutritional status, 48 weeks|bone density, 48 weeks
|
| Sponsor/Collaborators: |
Sponsor: Leiden University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-04
|
| Completion Date: |
2009-05
|
| Results First Posted: |
|
| Last Update Posted: |
2008-10-01
|
| Locations: |
Medisch Centrum Haaglanden, Den Haag, Z-Holland, 2512va, Netherlands|Haga Ziekenhuis, Den Haag, Z-Holland, 2545ch, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT00169923
|
